open access

Vol 76, No 5 (2018)
Short communications
Published online: 2018-05-10
Submitted: 2017-11-29
Accepted: 2018-02-12
Get Citation

Heart rate variability during and after chemotherapy with anthracycline in patients with breast cancer

Paweł Stachowiak, Marta Milchert-Leszczyńska, Michał Falco, Andrzej Wojtarowicz, Robert Kaliszczak, Krzysztof Safranow, Zdzisława Kornacewicz-Jach
DOI: 10.5603/KP.2018.0098
·
Kardiol Pol 2018;76(5):914-916.

open access

Vol 76, No 5 (2018)
Short communications
Published online: 2018-05-10
Submitted: 2017-11-29
Accepted: 2018-02-12

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Heart rate variability during and after chemotherapy with anthracycline in patients with breast cancer

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 76, No 5 (2018)

Pages

914-916

Published online

2018-05-10

DOI

10.5603/KP.2018.0098

Bibliographic record

Kardiol Pol 2018;76(5):914-916.

Authors

Paweł Stachowiak
Marta Milchert-Leszczyńska
Michał Falco
Andrzej Wojtarowicz
Robert Kaliszczak
Krzysztof Safranow
Zdzisława Kornacewicz-Jach

References (10)
  1. Stachowiak P, Kornacewicz-Jach Z, Safranow K. Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy. Arch Med Sci. 2014; 10(5): 1007–1018.
  2. Thayer JF, Sternberg E. Beyond heart rate variability: vagal regulation of allostatic systems. Ann N Y Acad Sci. 2006; 1088: 361–372.
  3. Zamorano J, Lancellotti P, Muñoz D, et al. Stanowisko ESC dotyczące toksycznego wpływu leczenia onkologicznego na układ sercowo-naczyniowy w 2016 roku, opracowane pod auspicjami Komisji ESC do spraw Wytycznych Postępowania [Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines]. Kardiol Pol. 2016; 74(11): 1193–1233.
  4. Asensio-López MC, Soler F, Sánchez-Más J, et al. Early oxidative damage induced by doxorubicin: Source of production, protection by GKT137831 and effect on Ca(2+) transporters in HL-1 cardiomyocytes. Arch Biochem Biophys. 2016; 594: 26–36.
  5. Kasinath NS, Malak O, Tetzlaff J. Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. Can J Anaesth. 2003; 50(3): 229–231.
  6. Kilickap S, Barista I, Akgul E, et al. Early and late arrhythmogenic effects of doxorubicin. South Med J. 2007; 100(3): 262–265.
  7. Poręba M, Poręba R, Gać P, et al. Heart rate variability and heart rate turbulence in patients with hematologic malignancies subjected to high-dose chemotherapy in the course of hematopoietic stem cell transplantation. Ann Noninvasive Electrocardiol. 2014; 19(2): 157–165.
  8. Fagundes CP, Murray DM, Hwang BS, et al. Sympathetic and parasympathetic activity in cancer-related fatigue: more evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology. 2011; 36(8): 1137–1147.
  9. Panissa VLG, Cal Abad CC, Julio UF, et al. High-Intensity Intermittent Exercise and its Effects on Heart Rate Variability and Subsequent Strength Performance. Front Physiol. 2016; 7: 81.
  10. Lin H, Chen XH, Wu ZH, et al. [Association of pro-B-type natriuretic peptide levels with heart rate variability in diabetic patients]. Nan Fang Yi Ke Da Xue Xue Bao. 2015; 35(1): 146–148.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl